Sooch Mina
Insider CIK 1674006 · OCUP President and CEO, Director · BIVI Director · GEMP President & CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2023-01-10 | 2023-01-12 | 201,683 | — | $0 | 201,683 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2023-01-10 | 2023-01-12 | 134,456 | — | $0 | 430,501 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | X Exercise deriv | 2022-09-06 | 2022-09-08 | 1,023 | — | $0 | 0 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | X Exercise | 2022-09-06 | 2022-09-08 | 1,023 | — | $0 | 426,045 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy | 2022-05-20 | 2022-05-23 | 12,500 | $2.02 | $25.3K | 425,022 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy | 2022-05-19 | 2022-05-23 | 12,500 | $2.07 | $25.9K | 412,522 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2022-01-28 | 2022-02-01 | 200,000 | — | $0 | 200,000 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy deriv | 2020-11-19 | 2020-11-25 | 17,413 | — | $0 | 17,413 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy deriv | 2020-11-19 | 2020-11-25 | 2,046 | — | $0 | 2,046 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy | 2020-11-19 | 2020-11-25 | 11,524 | — | $0 | 800,044 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2020-11-11 | 2020-11-13 | 130,000 | — | $0 | 130,000 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2020-11-05 | 2020-11-09 | 158,475 | — | $0 | 158,475 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2020-11-05 | 2020-11-09 | 178,284 | — | $0 | 178,284 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2020-11-05 | 2020-11-09 | 788,520 | — | $0 | 788,520 | SEC↗ |
| BIVI BIOVIE INC. | A Award | 2019-01-02 | 2019-02-05 | 200,000 | $0.04 | $8.0K | 813,636 | SEC↗ |
| BIVI BIOVIE INC. | A Award | 2018-04-30 | 2018-08-14 | 150,000 | $0.02 | $3.0K | 613,636 | SEC↗ |
| BIVI BIOVIE INC. | A Award | 2018-01-02 | 2018-08-14 | 200,000 | $0.15 | $30.0K | 463,636 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2016-11-25 | 2016-11-29 | 120,000 | — | $0 | 600,000 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2016-09-30 | 2016-10-03 | 120,000 | — | $0 | 480,000 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion deriv | 2016-08-10 | 2016-08-12 | 11,078 | — | $0 | 0 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion deriv | 2016-08-10 | 2016-08-12 | 0 | — | $0 | 0 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | J Other | 2016-08-10 | 2016-08-12 | 1,212 | $6.71 | $8.1K | 12,290 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion | 2016-08-10 | 2016-08-12 | 27,141 | $6.71 | $182.1K | 39,431 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | P Buy | 2016-08-10 | 2016-08-12 | 52,500 | $10.00 | $525.0K | 693,732 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion | 2016-08-10 | 2016-08-12 | 11,078 | — | $0 | 11,078 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2016-08-04 | 2016-08-08 | 360,000 | — | $0 | 360,000 | SEC↗ |